Category Archives: Corporate

Department of Justice Sues Anthem, Aetna to Block Insurer Mergers

Anthem Inc. (Indianapolis IN) said its proposed $48 billion merger with rival health insurer Cigna Corp. (Bloomfield CT) will lower consumer costs and extend coverage to more people, in response… Read more »

GlaxoSmithKline Taps Apple’s ResearchKit for Arthritis Study

GlaxoSmithKline PLC (London) has started a rheumatoid arthritis study using Apple Inc.’s (Cupertino CA) ResearchKit, marking the first time a drugmaker has used the health system for the iPhone to… Read more »

Aetna Said to Meet with DOJ on Friday about Humana Deal

Aetna Inc. (Hartford CT) executives met with top Justice Department antitrust officials on Friday to convince the government that asset sales it proposed would address potential competitive problems that could… Read more »

Medtronic Buys HeartWare for $1.1 Billion

Medtronic PLC (Dublin) said it agreed to acquire HeartWare International Inc. (Framingham MA) for $1.1 billion, adding more heart-treatment products to the giant medical-device maker. Medtronic will pay $58 a share in cash for… Read more »

U.S. Doctors, Hospitals Receive Billions from Drug, Device Makers; Report

Drug and device makers sustained their payments to doctors and teaching hospitals at nearly $6.5 billion last year, according to the figures released Thursday from a federal database. And physicians… Read more »

Wall Street Ponders Brexit’s Impact on Drug, Biotech Stocks

In a historic vote Thursday, Britain has decided to leave the European Union. And, swallowing hard, financial markets around the world are not taking the news very well. Stateside, the Dow… Read more »

Brexit Bargain Stocks Require Creative Mindset, Risk Tolerance

Frenzied bargain-hunters will immediately delve into the carnage of markets in the post-Brexit earthquake. Analysts advise caution but, more importantly, think creatively. The most obvious places to look are among… Read more »